Genomma Lab Internacional, S.A.B. de C.V. (BMV:LAB.B)
Mexico · Delayed Price · Currency is MXN 14.64
-0.19 (-1.28%)
At close: Jun 12, 2026
Genomma Lab Internacional Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Genomma Lab Internacional stock has a consensus rating of "Buy" and an average price target of $25.40. The average 1-year stock price forecast is 73.50% higher than the current stock price, while the lowest is $20.00 (+36.61%) and the highest is $30.00 (+104.92%).
Price Target: $25.40 (+73.50%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Genomma Lab Internacional stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
18.32B
from 17.54B
Increased by 4.46%
Revenue Next Year
19.24B
from 18.32B
Increased by 4.99%
EPS This Year
2.09
from 1.61
Increased by 30.03%
EPS Next Year
2.15
from 2.09
Increased by 2.66%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is MXN.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 20.0B | ||
| Avg | 18.3B | ||
| Low | 17.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.9% | ||
| Avg | 4.5% | ||
| Low | -0.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.56 | ||
| Avg | 2.09 | ||
| Low | 1.79 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 59.0% | ||
| Avg | 30.0% | ||
| Low | 11.2% |